World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
70
Citations
28674
World Ranking
6858
National Ranking
127

Overview

Michael Ristow is affiliated with the École Polytechnique Fédérale de Lausanne in Switzerland and conducts research primarily in the fields of Biochemistry, Genetics and Molecular Biology, and Medicine. Their work spans several subfields, notably Molecular Biology, Aging, Physiology, Plant Science, and Ecology, Evolution, Behavior and Systematics.

The scientist's research topics cover a diverse range related to genetics and metabolism, including:

  • Genetics, Aging, and Longevity in Model Organisms
  • Mitochondrial Function and Pathology
  • Adipose Tissue and Metabolism
  • Metabolism, Diabetes, and Cancer
  • Botany and Plant Ecology Studies
  • Plant and animal studies
  • Ecology and Vegetation Dynamics Studies

Recent publications associated with Michael Ristow include:

  • Natural products in drug discovery: advances and opportunities (2021), Nature Reviews Drug Discovery
  • Interrelation between ROS and Ca2+ in aging and age-related diseases (2020), Redox Biology
  • Green tea catechins EGCG and ECG enhance the fitness and lifespan of Caenorhabditis elegans by complex I inhibition (2021), Aging
  • Evolutionarily conserved transcription factors as regulators of longevity and targets for geroprotection (2022), Physiological Reviews
  • Redox-mediated regulation of aging and healthspan by an evolutionarily conserved transcription factor HLH-2/Tcf3/E2A (2020), Redox Biology

Michael Ristow frequently publishes in several scientific venues, with notable contributions in the following journals:

  • Aging
  • Nature Communications
  • Kochia
  • Redox Biology
  • Basic and Applied Ecology

Their collaborative work involves repeated partnerships with several co-authors, including:

  • Kim Zarse
  • Fabian Fischer
  • Corina T. Madreiter-Sokolowski
  • Carolin Thomas
  • Giovanna Grigolon

Best Publications

  • Natural products in drug discovery: advances and opportunities.

    Atanas G Atanasov;Sergey B Zotchev;Verena M Dirsch

  • Inflammatory Cytokines and the Risk to Develop Type 2 Diabetes: Results of the Prospective Population-Based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study

    Joachim Spranger;Anja Kroke;Matthias Möhlig;Kurt Hoffmann

  • Glucose Restriction Extends Caenorhabditis elegans Life Span by Inducing Mitochondrial Respiration and Increasing Oxidative Stress

    Tim J. Schulz;Kim Zarse;Anja Voigt;Nadine Urban

  • How increased oxidative stress promotes longevity and metabolic health: The concept of mitochondrial hormesis (mitohormesis)

    Michael Ristow;Kim Zarse

  • Extending life span by increasing oxidative stress.

    Michael Ristow;Sebastian Schmeisser

  • Obesity associated with a mutation in a genetic regulator of adipocyte differentiation.

    M Ristow;D Müller-Wieland;A Pfeiffer;W Krone

  • Animal models of obesity and diabetes mellitus

    Maximilian Kleinert;Christoffer Clemmensen;Susanna M Hofmann;Mary C Moore

  • Muscle-specific PPARγ-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones

    Andrew W. Norris;Lihong Chen;Simon J. Fisher;Ildiko Szanto

  • Mitohormesis: Promoting Health and Lifespan by Increased Levels of Reactive Oxygen Species (ROS).

    Michael Ristow;Kathrin Schmeisser

  • Neurodegenerative disorders associated with diabetes mellitus

    Michael Ristow

  • Consuming fructose-sweetened beverages increases body adiposity in mice

    Hella Jürgens;Wiltrud Haass;Tamara R. Castañeda;Annette Schürmann

  • Impaired Insulin/IGF1 Signaling Extends Life Span by Promoting Mitochondrial L-Proline Catabolism to Induce a Transient ROS Signal

    Kim Zarse;Kim Zarse;Sebastian Schmeisser;Sebastian Schmeisser;Marco Groth;Steffen Priebe

  • Unraveling the Truth About Antioxidants: Mitohormesis explains ROS-induced health benefits

    Michael Ristow

  • The yeast frataxin homolog Yfh1p plays a specific role in the maturation of cellular Fe/S proteins

    Ulrich Mühlenhoff;Nadine Richhardt;Michael Ristow;Gyula Kispal

  • Loss of the Antiangiogenic Pigment Epithelium-Derived Factor in Patients With Angiogenic Eye Disease

    Joachim Spranger;Martin Osterhoff;Manja Reimann;Matthias Möhlig

  • Do antioxidant supplements interfere with skeletal muscle adaptation to exercise training

    Troy L. Merry;Michael Ristow

  • RIP-Cre Revisited, Evidence for Impairments of Pancreatic β-Cell Function

    Ji-Yeon Lee;Michael Ristow;Xueying Lin;Morris F. White

  • Frataxin activates mitochondrial energy conversion and oxidative phosphorylation

    Michael Ristow;Markus F. Pfister;Andrew J. Yee;Markus Schubert

  • Euglycemic hyperinsulinemia, but not lipid infusion, decreases circulating ghrelin levels in humans

    Matthias Möhlig;J. Spranger;B. Otto;M. Ristow

  • The polycystic ovary syndrome per se is not associated with increased chronic inflammation

    Matthias Möhlig;Joachim Spranger;Martin Osterhoff;Michael Ristow

Frequent Co-Authors

Reinhard Guthke
Reinhard Guthke Leibniz Association
Marco Groth
Marco Groth Leibniz Institute on Aging – Fritz Lipmann Institute
Matthias H. Tschöp
Matthias H. Tschöp Technical University of Munich
Christoph Englert
Christoph Englert Friedrich Schiller University Jena
Matthias Platzer
Matthias Platzer Leibniz Association
C. Ronald Kahn
C. Ronald Kahn Harvard University
Stefan Schuster
Stefan Schuster Friedrich Schiller University Jena
Georg Brabant
Georg Brabant University of Lübeck
Hindrik Mulder
Hindrik Mulder Lund University
Andreas Ziegler
Andreas Ziegler University of Ulm

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Michael Ristow

Trending Scientists